Skip to main content
. Author manuscript; available in PMC: 2012 Aug 17.
Published in final edited form as: Bioconjug Chem. 2011 Aug 1;22(8):1638–1644. doi: 10.1021/bc200201e

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1A Cutaway drawing showing liposomal nanoparticle lipid bilayer (inset) and cyclic RGD peptides bound to the exterior liposomal surface. The QDs denoted by filled red circles are conjugated to a lipid moiety and reside inside and external to the bilayer. The liposome is in effect initiated at these QD-lipid conjugates and forms around them. The interior volume of this liposome is aqueous, but can be filled with a hydrogel to facilitate the loading of a broad range of drug chemotypes.

Figure 1B Schematic diagram depicting the conjugation of the QD and the DPPE-SH lipid prior to liposomal nanoparticle assembly. The first step is to couple the QD to the linker. The maleamide group of the linker reacts with the lipid-thiol to create a stable thioether bond.

Figure 1C IR spectroscopy, the lower tracing shows the spectrum for QDs alone. The top tracing shows the spectrum of the putative lipid-QD conjugate. The doublet resulting from stretch of the amide bond is clearly indicated and is not present within the QD alone tracing. This data provides strong evidence that QD-lipid conjugation was successful. Fluorescence intensity of the QD800 nanocrystals was not diminished by encapsulation (data not shown).